Fibrodysplasia Ossificans Progressiva Market

The total diagnosed prevalent population of Fibrodysplasia Ossificans Progressiva in the 7MM was 567 in 2017. Females were found to be more affected by Fibrodysplasia Ossificans Progressiva as compared to males. Similarly, a higher prevalence is diagnosed for the age group 20-29.

Increase in research and development, upcoming launch and approval of therapies, awareness of disease are some of the key factors expected to drive the Fibrodysplasia Ossificans Progressiva market in the upcoming years.

The key players in Fibrodysplasia Ossificans Progressiva Market includes Ipsen, Regeneron Pharmaceuticals, AstraZeneca/Amsterdam UMC, Incyte Corporation, Kyoto University/ Takeda and many others.

For more detailed information on Fibrodysplasia Ossificans Progressiva Market, visit: https://www.delveinsight.com/report-store/fibrodysplasia-ossificans-progressiva-fop-market